Sara Bjursten

Statistics

Publications

Citations

167

H-Index

Active since

2018

Affiliations

Sahlgrenska University Hospital(Current)

University of Gothenburg

National Hospital for Neurology and Neurosurgery

Karolinska Institutet

University College London

Sara Bjursten is an author at Sahlgrenska University Hospital specializing in immune checkpoint inhibitors, oncology, and checkpoint inhibitor therapy.

ORCID

Publications per year

2018–2024

Publications

Real-world data on PD-1 inhibitor therapy in metastatic melanoma

Anna Arheden, Joanna Skalenius, Sara Bjursten et al. · Acta Oncologica · 2019 · 44 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Checkpoint inhibitor-induced sarcoid reaction mimicking bone metastases

Henrik Jespersen, Sara Bjursten, Lars Ny et al. · The Lancet Oncology · 2018 · 32 citations

Medicine, Oncology, Pharmacology +14

Early rise in brain damage markers and high ICOS expression in CD4+ and CD8+ T cells during checkpoint inhibitor-induced encephalomyelitis

Sara Bjursten, Ankur Pandita, Zhiyuan Zhao et al. · Journal for ImmunoTherapy of Cancer · 2021 · 28 citations · Full text

Life Sciences, Immunology, Neurology +17

Concentrations of S100B and neurofilament light chain in blood as biomarkers for checkpoint inhibitor–induced CNS inflammation

Sara Bjursten, Zhiyuan Zhao, Hifaa Al Remawi et al. · EBioMedicine · 2024 · 27 citations · Full text

Life Sciences, Immunology, Oncology +17

Intussusceptive Angiogenesis in Human Metastatic Malignant Melanoma

Ankur Pandita, Matias Ekstrand, Sara Bjursten et al. · American Journal Of Pathology · 2021 · 24 citations · Full text

Medicine, Cancer Biology, Oncology +16

1–5 of 6